MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
Authors
Keywords
Glioblastoma multiforme, Polyploidy, Apoptosis, Cancer treatment, Cell staining, Flow cytometry, Phosphorylation, Propidium iodide staining
Journal
PLoS One
Volume 11, Issue 10, Pages e0165107
Publisher
Public Library of Science (PLoS)
Online
2016-10-27
DOI
10.1371/journal.pone.0165107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
- (2015) Christopher T. Cummings et al. Oncotarget
- UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
- (2014) Weihe Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cellular senescence: from physiology to pathology
- (2014) Daniel Muñoz-Espín et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- EGFR and EGFRvIII in Glioblastoma: Partners in Crime
- (2013) Gelareh Zadeh et al. CANCER CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Molecular Pathways: MERTK Signaling in Cancer
- (2013) C. T. Cummings et al. CLINICAL CANCER RESEARCH
- MERTK receptor tyrosine kinase is a therapeutic target in melanoma
- (2013) Jennifer Schlegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
- (2013) L N Brandao et al. Blood Cancer Journal
- Interleukins in glioblastoma pathophysiology: implications for therapy
- (2012) YT Yeung et al. BRITISH JOURNAL OF PHARMACOLOGY
- Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
- (2012) Hua Mao et al. CANCER INVESTIGATION
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme
- (2012) Y Wang et al. ONCOGENE
- Novel Survivin Inhibitor YM155 elicits Cytotoxicity in Glioblastoma Cell Lines with Normal or Deficiency DNA-Dependent Protein Kinase Activity
- (2012) Pei Chun Lai et al. Pediatrics and Neonatology
- RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
- (2011) S. Hendruschk et al. NEURO-ONCOLOGY
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
- (2010) A. K. Keating et al. MOLECULAR CANCER THERAPEUTICS
- A Senescence-Like Cell-Cycle Arrest Occurs During Megakaryocytic Maturation: Implications for Physiological and Pathological Megakaryocytic Proliferation
- (2010) Rodolphe Besancenot et al. PLOS BIOLOGY
- Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells
- (2008) T Saito et al. BRITISH JOURNAL OF CANCER
- Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme
- (2008) M. Hutterer et al. CLINICAL CANCER RESEARCH
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now